Sort by
Refine Your Search
-
-targeted radionuclide therapy. These drugs, such as Novartis’ recently approved Pluvicto for prostate cancer, may destroy the salivary glands because these tissues also express PSMA. This can cause severe
Searches related to physics
Enter an email to receive alerts for physics "Novartis" positions